Corifollitropin alfa, also known as Elonva is used in women undergoing fertility treatment to stimulate the development of more than one mature egg (oocyte) at a time in the ovaries. This drug used together with a gonadotropin-releasing hormone (GnRH) antagonist, a type of medicine also used in fertility treatments. Elonva is available only by prescription ....
Controlled ovarian stimulation in cases of women who are undergoing fertility treatment to stimulate the development of more than one mature egg simultaneously in the ovaries in combination with a gonadotrophin-releasing hormone (GnRH) antagonist (a type of medicine also used in fertility treatments).
Instituto Bernabeu, Alicante, Spain
Enrico Papaleo, Milan, Italy
Policlinico di Modena, Modena, Modena - MO, Italy
Centro de Reproduçao Humana Insemine, Porto Alegre, RGS, Brazil
Hospital de Clinicas de Porto Alegre, Porto Alegre, RGS, Brazil
Physiopathology of Reproduction and IVF Unit, S. Anna Hospital, Torino, Italy
AZ Jan Palfijn, Gent, Oost-Vlaanderen, Belgium
UZ Brussel, Brussels, Belgium
Hosp das Clinicas da Faculdade de Medicina da Univ de Sao Paulo ( Site 0015), Sao Paulo, Brazil
Hospital Infantil de Mexico Federico Gomez ( Site 0006), Mexico City, Mexico
City children polyclinic #44 ( Site 0025), Saint Petersburg, Russian Federation
Hospital Quiron Dexeus, Barcelona, Spain
Research Center for Genetics and Reproductive Health, Ho Chi Minh City, Vietnam
My Duc Hospital, Ho Chi Minh City, Vietnam
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.